|Day Low/High||52.17 / 52.94|
|52 Wk Low/High||49.03 / 74.94|
The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.
Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.
Apparently, unless the Iranian military simply does not train on their weapons, which I do not believe, the exercise was one of saving face... for now.
The upcoming quarterly report for WBA might be a market mover, but the charts and indicators of CVS show a healthy stock ready to rise.
Let's review 2019 performance of RMPIA in relation to stock indexes and see what's ahead.
Watch for analysts and strategists to turn into armageddonists forgetting that China's the real issue.
Also: People's Bank of China, the Fed, U.S./China trade deal, Brexit, USMCA.
Wrong valuations -- such as those in Conagra Brands and Rite Aid -- exist, and they can make you money.
Stocks of GE and Walgreens Boots Alliance are examples of 'Dogs of the Dow' that could surprise on the upside.
I see upside back to above $70 regardless of whether the company gets taken private.
Plus, a glance at news about Disney+, Boeing's 737 Max and Alphabet's "Project Nightingale."
Everywhere I go I hear the smart money is betting on a recession, that earnings will be down, but every day something contradicts these bears.
At some point the market's inconsistency will resolve itself either way.
I'm all in favor of mergers and acquisitions -- the more we get, the higher the stock market goes -- but I am not in favor of making conclusions based on tips about deals.
Reports of two potentially major buyouts show the risks of late-cycle corporate bond investing.
The RMPIA's 3.8% jump even beat the Nasdaq Composite Index's 3.7% October climb.
The odds of a Fed December rate cut are now very low. I think the marketplace handles that just fine, as long as the statement with this week's expected cut does not sound too tough, or too cautious.
Rest up for a busy week that includes earnings from Apple, Facebook and Starbucks.
RMPIA is up 20.9% in the first nine months of 2019.
In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.
We suspect the new short-term uptrend has some degree of validity
There are a number of RMPIA companies that will be beneficiaries of Back to School and holiday spending.
By selling out of big losers prior to the quarter's close, portfolio managers can hide the stocks from clients, but some downtrodden shares could be ripe for bounces next week, so here's my list.
Let's stand back a little and get some perspective on how prices have behaved.
The G-20 Summit in Japan could hold more intrigue than just the planned meeting between President Trump and Xi.
Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.
RMPIA outperformed once gain during April.